Ryan Specialty (NYSE:RYAN) Downgraded by Wells Fargo & Company to Equal Weight

Ryan Specialty (NYSE:RYAN) was downgraded by equities researchers at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Friday, MarketBeat.com reports. They currently have a $31.00 price target on the stock. Wells Fargo & Company‘s target price would suggest a potential downside of 10.80% from the company’s previous close.

Other research analysts have also recently issued research reports about the company. Weiss Ratings cut Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. Mizuho lowered their price target on shares of Ryan Specialty from $44.00 to $42.00 and set a “neutral” rating on the stock in a research note on Monday, April 13th. Royal Bank Of Canada began coverage on shares of Ryan Specialty in a report on Tuesday, March 17th. They issued an “outperform” rating and a $45.00 price target for the company. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $55.00 to $49.00 and set an “outperform” rating for the company in a research note on Tuesday, April 7th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating on the stock in a report on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $50.59.

Ryan Specialty Trading Down 1.4%

NYSE RYAN opened at $34.75 on Friday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. The stock has a market capitalization of $9.18 billion, a P/E ratio of 82.75, a P/E/G ratio of 0.95 and a beta of 0.71. Ryan Specialty has a 52-week low of $31.50 and a 52-week high of $72.50. The firm has a 50-day moving average price of $36.08 and a 200 day moving average price of $46.46.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.04. The company had revenue of $795.23 million for the quarter, compared to analyst estimates of $781.44 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm’s revenue for the quarter was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.39 EPS. Equities research analysts expect that Ryan Specialty will post 2.24 EPS for the current year.

Insider Activity

In other news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the completion of the acquisition, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 52.03% of the stock is owned by corporate insiders.

Institutional Trading of Ryan Specialty

Several hedge funds and other institutional investors have recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. raised its holdings in Ryan Specialty by 79.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock valued at $389,910,000 after acquiring an additional 3,353,926 shares during the last quarter. Capital World Investors grew its position in shares of Ryan Specialty by 0.3% in the fourth quarter. Capital World Investors now owns 6,640,638 shares of the company’s stock valued at $342,856,000 after purchasing an additional 17,082 shares during the period. Vulcan Value Partners LLC increased its stake in Ryan Specialty by 631.7% in the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock valued at $238,536,000 after purchasing an additional 3,989,502 shares during the last quarter. Principal Financial Group Inc. increased its stake in Ryan Specialty by 21.1% in the third quarter. Principal Financial Group Inc. now owns 4,392,717 shares of the company’s stock valued at $247,576,000 after purchasing an additional 765,428 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. lifted its position in Ryan Specialty by 9.3% during the fourth quarter. Montrusco Bolton Investments Inc. now owns 4,343,116 shares of the company’s stock worth $218,010,000 after buying an additional 368,247 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations: EPS $0.47 vs. Street $0.43 and revenue $795.2M vs. $781.4M consensus; revenue was up ~15.2% year-over-year, driven by ~11.8% organic growth — a clear sign of top-line momentum. BusinessWire Q1 Release
• Positive Sentiment: Dividend announced: company declared a quarterly dividend of $0.13/share (annualized yield ~1.5%), ex-dividend date May 12 and payable May 26 — supports income-oriented investors and signals confidence in cash flow.
• Neutral Sentiment: Coverage and detail pieces: multiple outlets note the beat and provide deeper metric context (net margin ~7.0%, ROE ~46.4%) and replay of the conference call for investors wanting management commentary. MarketBeat Conference Call / Transcript
• Neutral Sentiment: Previews and snapshots: earnings previews and Q1 snapshots circulated ahead of and after the print, useful for analysts digging into quarter drivers and segment performance. MSN Q1 Coverage
• Negative Sentiment: Technical and valuation/financial-structure headwinds: the stock remains below its 200-day moving average (50-day is under 200-day), the shares trade at a high P/E (~82.8) and the company carries elevated leverage (debt/equity ~2.62) — these factors can limit upside and make the name sensitive to any guidance/margin softness or broader risk-off flows.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.